Annual Shareholders Equity
$46.14 M
+$20.60 M+80.69%
September 1, 2024
Summary
- As of February 7, 2025, CTOR annual stockholders equity is $46.14 million, with the most recent change of +$20.60 million (+80.69%) on September 1, 2024.
- During the last 3 years, CTOR annual shareholders equity has risen by +$9.87 million (+27.22%).
- CTOR annual shareholders equity is now at all-time high.
Performance
CTOR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CTOR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +80.7% | - |
| 3 y3 years | +27.2% | - |
| 5 y5 years | +27.2% | - |
CTOR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +80.7% | ||
| 5 y | 5-year | at high | +80.7% | ||
| alltime | all time | at high | +80.7% |
Citius Oncology Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $46.14 M(+80.7%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | $25.54 M(-29.6%) | - |
| Sep 2022 | $36.27 M | - |
FAQ
- What is Citius Oncology annual stockholders equity?
- What is the all time high annual shareholders equity for Citius Oncology?
- What is Citius Oncology annual shareholders equity year-on-year change?
What is Citius Oncology annual stockholders equity?
The current annual shareholders equity of CTOR is $46.14 M
What is the all time high annual shareholders equity for Citius Oncology?
Citius Oncology all-time high annual stockholders equity is $46.14 M
What is Citius Oncology annual shareholders equity year-on-year change?
Over the past year, CTOR annual stockholders equity has changed by +$20.60 M (+80.69%)